Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Host-pathogen interactions in the 21st century

Bali Pulendran, Robert A Seder

    Current Opinion in Immunology
    |June 16, 2005
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pharmacokinetics and pharmacodynamics of a long-acting monoclonal antibody against malaria in African adults.

    The Journal of clinical investigation·2026
    Same author

    A proteome-wide atlas of humoral immunity to <i>Mycobacterium tuberculosis</i> across the spectrum of disease.

    Frontiers in immunology·2026
    Same author

    Spatiotemporal dynamics of adoptively transferred stem-like CD8<sup>+</sup> T cells in the tumor microenvironment following vaccination.

    bioRxiv : the preprint server for biology·2026
    Same author

    Mannosylated nanoparticle immunogens enhance the circumsporozoite protein-specific B cell response and improve protection against sporozoite challenge.

    bioRxiv : the preprint server for biology·2026
    Same author

    Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21.

    NPJ vaccines·2026
    Same author

    Safety and efficacy of the monoclonal antibody L9LS for malaria prevention in children exposed to perennial malaria transmission in Kenya: a randomised, double-blind, placebo-controlled, phase 2 trial.

    Lancet (London, England)·2026